Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05204537 · ClinicalTrials.gov registry record
The Role of Surgery in Patients With Coronavirus Disease - 19 (COVID-19) Related Thoracic Complications
A clinical trial, sponsored by University of Milano Bicocca.
- Completed
- Registry status
- 83
- Enrollment target
NCT05204537: Completed study, sponsored by University of Milano Bicocca.
NCT05204537 is a clinical trial that has completed, run by University of Milano Bicocca. The registered enrollment target is 83 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05204537 has completed, sponsored by University of Milano Bicocca.
- COMPLETED
- Registry status
- 83 participants
- Enrollment target
Study Summary
Thoracic complications directly or indirectly consequence of Coronavirus Disease 2019 (COVID-19) (including either pathologies strictly related to the infection, or iatrogenic effects of therapeutic attempts to treat it) have been described during the pandemic. Many of the above conditions often require a surgical approach but, based on published data reporting high early postoperative morbidity and mortality, many experts initially advised against any referral to surgery in COVID-19 patients. Therefore, the issue is if salvage surgical approach should be always excluded or could be considered when it represents the only remaining effective option. In the absence of solid data and recommendations, this is a demanding challenge for thoracic surgeons. The investigators have coordinated a multicenter study to collect the experience of several worldwide high-volume thoracic surgery departments. Their objective is to investigate efficacy and safety of surgery in COVID-19 patients who developed thoracic complications that required operative management.
Primary Outcome
Overall survival at 30 days from surgery
Interventions
- PROCEDURE Lung parenchyma resection
- PROCEDURE Empyemectomy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 83 participants |
| Start Date | 2020-03-01 |
| Est. Completion | 2022-03-30 |
What the finished NCT05204537 record still lists
NCT05204537 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 83 participants, a relatively small participant target.
The record links to 0 conditions, and to 2 interventions - of which Lung parenchyma resection is the first listed.
NCT05204537 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05204537 about?
NCT05204537 is a clinical study titled "The Role of Surgery in Patients With Coronavirus Disease - 19 (COVID-19) Related Thoracic Complications". Thoracic complications directly or indirectly consequence of Coronavirus Disease 2019 (COVID-19) (including either pathologies strictly related to the infection, or iatrogenic effects of therapeutic attempts to treat it) have been described during the pandemic. Many of the above conditions often re...
What is the current status of trial NCT05204537?
This trial is currently completed. The enrollment target is 83 participants. The study started on 2020-03-01. Estimated completion is 2022-03-30.
What interventions are being tested in trial NCT05204537?
The interventions under investigation include: Lung parenchyma resection (PROCEDURE), Empyemectomy (PROCEDURE).
Who is sponsoring clinical trial NCT05204537?
This trial is sponsored by University of Milano Bicocca, which has 3 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02974647 · 83 participants · Phase 2
Study of Ruxolitinib in Relapsed or Refractory T or NK Cell Lymphoma
- NCT03919292 · 83 participants · Phase 1
Neratinib + Valproate in Advanced Solid Tumors, w/Expansion Cohort in Ras-Mutated Ca
- NCT04626674 · 83 participants · Phase 1
A Gene Transfer Therapy Study to Evaluate the Safety of and Expression From Delandistrogene Moxeparvovec (SRP-9001) in Participants With Duchenne Muscular Dystrophy (DMD)
- NCT05277168 · 83 participants · Phase 1
A Trial TO Evaluate THE Safety, Tolerability, Pharmacokinetics, AND Efficacy OF Shr-a1904 IN Subjects With Advanced Solid Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI